RENTON HOLLINGS 4

What Happened

• Renton Hollings, a director of AnaptysBio (ANAB), had 6,030 restricted stock units (RSUs) vest on June 15, 2026 and these RSUs converted into 6,030 shares of common stock for no cash consideration. The Form 4 shows a conversion/exercise event (code M) reporting 6,030 shares acquired at $0.00 and a corresponding disposition of 6,030 derivative units (the RSUs) at $0.00. This was not a sale—he received shares from an award vesting.

Key Details

• Transaction date: June 15, 2026; Form 4 filed: June 17, 2026 (timely filing).
• Reported amounts: 6,030 shares acquired at $0.00; 6,030 RSU units disposed/converted at $0.00.
• Total cash value reported: $0 (shares issued on settlement of RSUs).
• Shares owned after transaction: not specified in the provided summary.
• Footnotes: F1—each RSU converts into one share upon settlement for no consideration; F2—100% of the RSUs vested on June 15, 2026, subject to continued service.
• Transaction code: M (exercise or conversion of a derivative security) used to report the RSU conversion.

Context

• This is an award vesting/settlement event, not an open-market purchase or sale—so it reflects compensation being paid out in stock rather than a trading decision. For derivative entries like this, Form 4s often show both the acquisition of shares and the disposition of the derivative instrument to make clear the RSUs were settled. There’s no indication of a sale or other disposition of the resulting shares in the provided data.